InvestorsHub Logo
Followers 44
Posts 13354
Boards Moderated 0
Alias Born 02/27/2005

Re: None

Friday, 04/16/2021 2:48:46 PM

Friday, April 16, 2021 2:48:46 PM

Post# of 233119
poor ph now buying india teatment drugs cause the price is cheaper lol cause india covid is blowing up.moreover LL way better than rem but ph
buying rem under csp.imo

https://doh.gov.ph/doh-press-release/DOH-AND-FDA-CLARIFY-CLAIMS-ON-THE-APPROVAL-OF-POTENTIAL-COVID-19-TREATMENTS-AND-CALLS-FOR-RESIGNATION-OF-THE-SOH

"The Philippines is importing medicines from India and making them available to lower-income households through village pharmacies through R.A. 9502 or Cheaper Medicines Act. Additionally, a Philippine Institute for Development Studies (PIDS) policy note explains that India has cheaper medicines since it is the home market effect. India is the second most populated country in the world and is a large home market for medicines hence, giving it an advantage in medicine prices compared to other countries.

The DOH and FDA categorically deny the insinuation that there are people from the department who financially benefit from the use of remdesivir and tocilizumab. The use of remdesivir and tocilizumab are based on WHO Solidarity Trials and are used only for critical and severe COVID-19 cases. Remdesivir and Tocilzumab are not yet recommended for the use of mild and asymptomatic cases. The WHO has yet set to set the appropriate treatment of COVID-19 patients and these are used to help in discovering effective therapeutics for COVID-19. Moreover, the Philippine Society for Microbiology and Infectious Diseases (PSMID) COVID-19 Living Recommendations suggest the use of remdesivir and tocilizumab as a treatment for patients with critical and severe COVID-19 cases. Remedesivir is used under Compassionate Special Permit and Tocilizumab is a registered anti-inflammatory drug"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News